News
Burrill & Company Announces Close of Burrill Brazil Fund I January 18, 2012 | Press Release
David Wetherell Joins Burrill & Company Venture Capital Group as Managing Director January 06, 2012 | Press Release
Global Financial Market Turmoil Overshadows Biotech Successes in 2011 January 03, 2012 | Press Release
See all News
Investments
Public & Past Performers
Aclara completed an IPO in 2000. 
Alexza completed and IPO in 2006.
BioMimetic Pharmaceuticals completed an IPO in 2006.
Acquired Elbion NV in 2009
Bruker BioSciences completed an IPO in 2001.
Corus Pharma was acquired by Gilead Sciences in 2006. 
CropDesign was acquired by BASF Plant Sciences in 2006.
Roche acquired BioImagene in 2010.
Endocyte completed an IPO in 2011.
Galapagos completed an IPO in 2005.
Gevo completed an IPO in 2011.
Immunicon completed an IPO in 2004.
Inhibitex completed an IPO in 2004.
Morphotek was acquired by Eisai in 2007.
Orchid completed an IPO in 2000.
Peplin was acquired by LEO Pharma in 2009 
Pharmasset completed an IPO in 2007.
Targacept completed an IPO in 2006.
Taiwan Liposome Company (TLC) completed an IPO in October 2011. 
Third Wave completed an IPO in 2001.